PharmNovo further strengthens the organisation
The Swedish pharmaceutical company PharmNovo AB, which is developing a new type of drug for neuropathic pain, announces that the team has been further strengthened in connection with the company now taking the step from preclinical to clinical development.PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical Trial Manager to continue the development of the company's drug candidate PN6047 for the treatment of neuropathic pain, so-called nerve pain. Inge Tarnow joins the team as the new Senior Project Manager and will lead and coordinate the work with